Evidence map›Paper›PMID 16475002›Full record

ArticleNeurochemical research2006

A novel aminopeptidase with highest preference for lysine.

Maria Hui, Koon-Sea Hui

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Maria HuiPeptide Research Laboratory, Neurochemistry Division, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY, 10962, USA.
Koon-Sea Hui
Nathan Kline Institute for Psychiatric Research · US

Funding

ENDOGENOUS ANTI-ENKEPHALINASE PEPTIDES IN BRAINR01DA006271 · NIDA · NEW YORK STATE OFFICE OF MENTAL HEALTH · PI HUI, KOON-SEA · 1991 to 1993
–
SMALL INSTRUMENTATION GRANTS15MH051893 · NIMH · NATHAN S. KLINE INSTITUTE FOR PSYCH RES · PI HUI, KOON-SEA · 1993 to 1993
–
NIDA NIH HHS 5R01DA06271NIMH NIH HHS S15MH51893
6 · The paper itself

Abstract

Neuropeptides are formed from sedentary precursors to smaller, active peptides by processing enzymes cleaving at paired basic residues. The process generates peptide intermediates with additional Lys or Arg residues at their NH(2) and COOH termini; the N-terminal basic amino acids are later removed by specific aminopeptidases. We report here a novel lysine-specific aminopeptidase (KAP) of ubiquitous distribution. The enzyme was resolved from puromycin-sensitive aminopeptidase (PSA), aminopeptidase B (APB), and neuron-specific aminopeptidase (NAP). It was purified by FPLC after (NH(4))(2)SO(4) precipitation. The purified KAP had a K(m) of 333 microM with a V(max) of 0.7 nmol Lys ssNA/min/mg protein. N-terminal basic amino acids, Lys in particular, were its favorable substrates. KAP was inhibited by chelating agents and by serine protease inhibitors. It was highly sensitive to aminopeptidase inhibitor bestatin, but insensitive to puromycin and amastatin, showing that KAP is distinct from PSA, NAP, and aminopeptidase A (APA). The 62,000-Da enzyme had a pH optimum at 7.5 and NaCl was its strongest activator. However, metals could not restore KAP's activity after it was dialyzed against EGTA. Our data indicated that rat KAP did not resemble any aminopeptidases as well as the microbial lysine aminopeptidases.

Indexed as

AminopeptidasesAnimalsEnzyme ActivationEnzyme InhibitorsHydrogen-Ion ConcentrationLysineMaleMolecular WeightNeuropeptidesRatsRats, Sprague-DawleySubstrate SpecificityTissue DistributionAminopeptidasesEnzyme InhibitorsLysinelysyl aminopeptidaseNeuropeptides

Identifiers

PMID16475002
OpenAlexW2035447435

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.